Evaluation and testing services (ETS) for vaccines and other biologics for infectious diseases

Active Indefinite Delivery Contract Awarded Last action

Contract number
75N93018D00013
Awardee
Awarding agency
Task orders
19 $62,017,388 obligated

Award facts

Combined order value
  • $62,017,388 Current, with exercised options
  • $95,002,149 Potential, with all options
Last date to order 81% complete
IDV ceiling 55% used
$112,000,000.00
Award type
Single award
Who can order
Only the awarding agency
Set-aside
No set-aside
Competition
Full and Open Competition · 2 offers Negotiated Proposal / Quote
Pricing
Cost Plus Fixed Fee

Award details come from SAM.gov/FPDS.

About this IDV

Written by GovTribe AI ·

The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, awarded this $112 million Indefinite Delivery Contract to Battelle Memorial Institute, a large nonprofit research and development organization, for "Evaluation and Testing Services (ETS) for Vaccines and Other Biologics for Infectious Diseases." The contract provides a comprehensive suite of preclinical, nonclinical, and clinical testing services to support a diverse collection of vaccine and biological product candidates across multiple scientific areas. This allows NIAID to obtain critical data for various investigators to acquire funding, partnerships, fulfill regulatory requirements, and prepare for clinical trials. The contract has no set-aside designation, and the work is primarily performed in Columbus, Ohio.

Through the base contract and numerous task orders, Battelle provides a range of services, including developing animal models for vaccine testing, evaluating monoclonal antibodies and therapeutic biologics, creating international standards for viruses like Ebola and Marburg, and supporting clinical sample testing for influenza, COVID-19, and other infectious disease vaccine candidates. These efforts align with NIAID's mission to conduct and support research to understand, treat, and prevent infectious diseases, which has been a critical focus during the COVID-19 pandemic.

Task orders

Task order Ordering agency Obligated Awarded
Hamster sarbecovirus challenge model for vaccine testing 75N93024F00001 National Institute of Allergy and Infectious Diseases (NIH) $2,365,162
Pivotal study to evaluate the efficacy of S315 MAB after parenteral challenge of diphtheria toxin in a guinea PIG model 75N93023F00002 National Institute of Allergy and Infectious Diseases (NIH) $1,088,261
Creation of a sudan ebolavirus international standard 75N93023F00001 National Institute of Allergy and Infectious Diseases (NIH) $657,850
Development of assays and reagents for monkeypox vaccines 75N93022F00004 National Institute of Allergy and Infectious Diseases (NIH) $3,833,162
Evaluation of clinical samples from influenza clinical trials 75N93022F00005 National Institute of Allergy and Infectious Diseases (NIH) $2,854,165
Creation of a marburgvirus international standard 75N93022F00003 National Institute of Allergy and Infectious Diseases (NIH) $656,189
Deep antibody profiling for RSV infection and vaccination 75N93022F00002 National Institute of Allergy and Infectious Diseases (NIH) $843,924
Clinical sample testing for zika virus vaccines 75N93022F00001 National Institute of Allergy and Infectious Diseases (NIH) $203,335
Preparedness for testing niaid priority vaccines in general safety toxicology studies 75N93021F00002 National Institute of Allergy and Infectious Diseases (NIH) $11,382,316
Clinical sample evaluation for anthrax vaccines, AV7909 and thermostable AV7909, vteu trial 17-0093 75N93021F00001 National Institute of Allergy and Infectious Diseases (NIH) $305,404
Qualification of a shigella serum bactericidal assay 75N93020F00005 National Institute of Allergy and Infectious Diseases (NIH) $634,745
Clinical sample testing for sars-COV-2 vaccine candidates 75N93020F00006 National Institute of Allergy and Infectious Diseases (NIH) $6,398,512
Clinical and NHP sample testing for sars-COV-2 vaccine and other biological product candidates 75N93020F00004 National Institute of Allergy and Infectious Diseases (NIH) $435,768
Development of assays and reagents for coronavirus vaccines 75N93020F00002 National Institute of Allergy and Infectious Diseases (NIH) $12,386,821
Immunogenicity and efficacy testing of medical countermeasures (vaccines and other biologics) against emerging… 75N93020F00003 National Institute of Allergy and Infectious Diseases (NIH) $3,494,557
Evaluate the immunological responses of human samples collected from phase I and phase II clinical trials of seasonal… 75N93020F00001 National Institute of Allergy and Infectious Diseases (NIH) $1,477,748
Clinical sample testing using intracellular flow cytometry using samples from a phase 1 clinical, OVX836; biod can… 75N93019F00366 National Institute of Allergy and Infectious Diseases (NIH) $612,804
1800013I battelle memorial institute; immunogenicity and efficacy testing of medical countermeasures (vaccines and… 75N93019F00131 National Institute of Allergy and Infectious Diseases (NIH) $11,516,755
Task order 1 base award; biod can 8470038 $132,813 75N93018F00001 National Institute of Allergy and Infectious Diseases (NIH) $869,911
Show all 19

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00016 $0
Supplemental Agreement for work within scope P00015 $0
Supplemental Agreement for work within scope P00014 $0
Supplemental Agreement for work within scope P00013 $0
Supplemental Agreement for work within scope P00012 $0
Supplemental Agreement for work within scope P00011 $0
Other Administrative Action P00010 $0
Supplemental Agreement for work within scope P00009 $0
Supplemental Agreement for work within scope P00008 $0
Supplemental Agreement for work within scope P00007 $0
Supplemental Agreement for work within scope P00006 $0
Other Administrative Action P00005 $0
Supplemental Agreement for work within scope P00004 $0
Supplemental Agreement for work within scope P00003 $0
Supplemental Agreement for work within scope P00002 $0
Supplemental Agreement for work within scope P00001 $0
Original award $0
Show all 17

Subawards

Subcontractor Amount Awarded
Texas Biomedical Research Institute 1800013I BATTELLE MEMORIAL INSTITUTE; IMMUNOGENICITY AND EFFICACY TESTING OF MEDICAL COUNTERMEASURES (VACCINES AND OTHER BIOLOGICS) AGAINST BSL-4 PATHOGENS IN… $1,281,436
Frontage Laboratories, Inc. PREPAREDNESS FOR TESTING NIAID PRIORITY VACCINES IN GENERAL SAFETY TOXICOLOGY STUDIES Develop Study Protocol draft $60,000
Frontage Laboratories, Inc. PREPAREDNESS FOR TESTING NIAID PRIORITY VACCINES IN GENERAL SAFETY TOXICOLOGY STUDIES AAHI GLP Tox Study $415,000
Integral Molecular Inc. CLINICAL SAMPLE TESTING FOR SARS-COV-2 VACCINE CANDIDATES SARS (Cov 2) $40,718
Amplifybio LLC PREPAREDNESS FOR TESTING NIAID PRIORITY VACCINES IN GENERAL SAFETY TOXICOLOGY STUDIES Protocol Development and study execution $722,311
Amplifybio LLC PREPAREDNESS FOR TESTING NIAID PRIORITY VACCINES IN GENERAL SAFETY TOXICOLOGY STUDIES protocol development and study execution $631,828
Leinco Technologies, Inc. CLINICAL SAMPLE TESTING FOR SARS-COV-2 VACCINE CANDIDATES anti-SARS-CoV-1 recombinant $40,509
Mriglobal PREPAREDNESS FOR TESTING NIAID PRIORITY VACCINES IN GENERAL SAFETY TOXICOLOGY STUDIES Next Generation COVID Vaccines $180,450
Integral Molecular Inc. CLINICAL SAMPLE TESTING FOR SARS-COV-2 VACCINE CANDIDATES Luciferase reporters $39,876
Zalgen Labs LLC PREPAREDNESS FOR TESTING NIAID PRIORITY VACCINES IN GENERAL SAFETY TOXICOLOGY STUDIES ELISA Kits $54,000
Inotiv, Inc. PREPAREDNESS FOR TESTING NIAID PRIORITY VACCINES IN GENERAL SAFETY TOXICOLOGY STUDIES Conduct Reproductive Tox Studies $963,211
Show all 11

Quick answers

Who was awarded contract 75N93018D00013?

75N93018D00013 was awarded to Battelle Memorial Institute by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 12, 2018.

How much is contract 75N93018D00013 worth?

Orders under 75N93018D00013 have obligated $62,017,388. Their combined potential value, with all options, is $95,002,149. 75N93018D00013's own ceiling is $112,000,000.

How many orders have been placed under contract 75N93018D00013?

19 orders have been placed under 75N93018D00013, the latest on September 6, 2024.

Who can order from contract 75N93018D00013?

75N93018D00013 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.

Was contract 75N93018D00013 competed?

The extent of competition for 75N93018D00013 was full and open competition. The government received 2 offers.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV
Try for free Login